iifl-logo-icon 1

Emmessar Biotech & Nutrition Ltd EGM

41
(1.26%)
Jul 5, 2024|03:40:00 PM

Emmessar Biotech CORPORATE ACTIONS

07/07/2023calendar-icon
06/07/2024calendar-icon
PurposeAnnouncement DateMeeting Date
EGM27 Oct 202324 Nov 2023
The Board of Directors held the additional Board Meeting to appoint an additional director and to fix the date of EGM for voting the resolution which was missed during the AGM. There may be delay in submitting UA Financial Results & Non Applicability Cert of Corp Governance for the quarter ending September 30, 2023. Due to the resolution of approving Statutory Auditors was missed during AGM. As intimated earlier, the company has called for EGM to get the resolution passed. Hence we request you to grant us an extension of time regarding submission of Un Audited Financial Results and the Non Applicability Certificate of the Corporate Governance (As Per BSE Announcement Dated on 01.11.2023) EGM will be held on Friday, November 24, 2023 at 11.00 am to take the approval of the shareholders on the missed resolution at AGM i.e. appointment of Statutory Auditors. The e-Voting period is from 21-11-2023 at 9 am till 23-11-2023 at 5 pm. EGM Notices sent to the investors. (As Per BSE Announcement Dated on 02/11/2023) We wish to inform you than an Extra-Ordinary General Meeting [EGM] of the Company was held on Friday, November 24, 2023, through Video Conferencing (VC) at 11.10 am and concluded at 12 Noon. The item of the business as mentioned in the EGM Notice dated October 27, 2023, has been transacted and the resolution have been passed by the members with requisite majority by way of remote e-Voting. (As per BSE Announcement Dated on 24/11/2023) In continuation to our earlier announcement in the Outcome of the AGM on 29-09-2023 and in the Outcome of EGM on 24-11-2023, we once again inform about the appointment of the Statutory Auditors by passing the resolution by the shareholders in the EGM held on 24-11-2023. This resolution was missed during the voting at the AGM. (As per BSE Announcement Dated on 25/11/2023)

Emmessar Biotech: Related News

No record found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.